Table 3. HRU during the follow-up period.
CCA-related† (N=1,298) | All-cause (N=1,298) | |
---|---|---|
Patients with medical services‡, N (%) | ||
Inpatient admission | 502 (38.7) | 830 (63.9) |
ICU admission | 186 (14.3) | 265 (20.4) |
Emergency room visit | 143 (11.0) | 512 (39.4) |
Home health care/hospice visit | 112 (8.6) | 296 (22.8) |
Outpatient visit | 778 (59.9) | 1,096 (84.4) |
Radiology visit | 573 (44.1) | 937 (72.2) |
Number of medical services per patient per month§, mean ± SD | ||
Inpatient admissions | 0.2±1.1 | 0.5±2.0 |
Inpatient length of stay per admission¶ | 4.4±17.2 | 4.9±17.1 |
ICU admissions | 0.1±0.9 | 0.1±1.0 |
ICU length of stay per admission¶ | 3.6±9.9 | 3.7±11.9 |
Emergency room visits | 0.0±0.1 | 0.1±0.3 |
Home health care/hospice visits | 0.1±0.4 | 0.2±1.1 |
Outpatient visits | 1.0±1.9 | 2.3±2.5 |
Radiology visits | 0.2±0.4 | 0.6±1.1 |
†, if any claim within an admission/visit had a diagnosis code for CCA, the entire visit was considered CCA-related; ‡, patients with any of the following medical services during their follow-up period were summarized; patients have varying length of follow up; §, per patient per month HRU was calculated based on the average of the number of admission(s) or visit(s) per patient divided by number of months in each patient’s follow-up; ¶, length of stay for inpatient and ICU admissions were calculated only among patients with at least one inpatient or ICU admission, respectively. CCA, cholangiocarcinoma; HRU, healthcare resource utilization; ICU, intensive care unit; SD, standard deviation.